Edition:
United Kingdom

Bellicum Pharmaceuticals Inc (BLCM.OQ)

BLCM.OQ on NASDAQ Stock Exchange Global Market

1.93USD
14 Jun 2019
Change (% chg)

$-0.03 (-1.53%)
Prev Close
$1.96
Open
$1.99
Day's High
$2.00
Day's Low
$1.88
Volume
128,859
Avg. Vol
95,337
52-wk High
$10.23
52-wk Low
$1.54

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 0.52 -0.554
FY 2018 Dec '18 0.31 -0.627
Sep '18 0.29 -0.549
Jun '18 0.36 -0.595
Mar '18 0.15 -0.683
FY 2017 Dec '17
Sep '17 0.13 -0.706
Jun '17 0.00 -0.739
Mar '17 0.13 -0.805
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-19 4 0.87 2.70 0.10 2.70
Quarter Ending Sep-19 4 0.85 2.70 0.10 2.70
Year Ending Dec-19 3 4.46 9.00 1.40 2.72
Year Ending Dec-20 4 13.70 38.30 1.50 58.55
Earnings (per share)
Quarter Ending Jun-19 4 -0.52 -0.38 -0.64 -0.55
Quarter Ending Sep-19 4 -0.51 -0.39 -0.66 -0.50
Year Ending Dec-19 4 -2.05 -1.72 -2.38 -2.51
Year Ending Dec-20 4 -1.70 -1.37 -2.02 -1.96
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.30 32.55
P/E High - Last 5 Yrs. -- 147.69 48.11
P/E Low - Last 5 Yrs. -- 47.94 23.41
Beta -- 1.08 0.87
Price to Sales (TTM) 1,169.61 49.50 8.43
Price to Book (MRQ) 3.08 10.13 5.27
Price to Tangible Book (MRQ) 3.08 13.74 6.74
Price to Cash Flow (TTM) -- 56.16 24.12
% Owned Institutions 57.02 3.71 1.65

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.35
Dividend Yield - 5 Year Avg -- 0.09 1.37
Dividend 5 Year Growth Rate -- 0.78 4.71
Payout Ratio(TTM) -- 7.02 39.59

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -100.00 206.05 13.45
Sales (TTM) vs TTM 1 Yr. Ago 13.73 49.05 8.04
Sales - 5 Yr. Growth Rate -- 22.77 10.84
EPS (MRQ) vs Qtr. 1 Yr. Ago -20.53 75.32 48.21
EPS (TTM) vs TTM 1 Yr. Ago -26.74 -- --
EPS - 5 Yr. Growth Rate -- 11.97 10.46
Capital Spending - 5 Yr. Growth Rate -- 9.11 14.68

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.24 2.18
Current Ratio (MRQ) 8.34 3.57 2.98
LT Debt to Equity (MRQ) 22.22 18.62 11.35
Total Debt to Equity (MRQ) 25.02 31.29 16.04
Interest Coverage (TTM) -- -43.11 28.45

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.27 52.39
Gross Margin - 5 Yr. Avg. -- 60.50 50.39
EBITD Margin (TTM) -24,512.38 -- --
EBITD - 5 Yr. Avg -- -110.91 12.41
Operating Margin (TTM) -25,442.11 -184.93 5.67
Operating Margin - 5 Yr. Avg. -- -127.41 8.00
Pre-Tax Margin (TTM) -26,033.13 -175.62 4.69
Pre-Tax Margin - 5 Yr. Avg. -- -133.20 8.28
Net Profit Margin (TTM) -26,033.13 -182.34 1.42
Net Profit Margin - 5 Yr. Avg. -- -137.59 4.69
Effective Tax Rate (TTM) -- 22.46 22.13
Effective Tax Rate - 5 Yr. Avg. -- 15.50 22.58

Efficiency

  Company industry sector
Revenue/Employee (TTM) 2,936 7,653,013 819,596,351
Net Income/Employee (TTM) -764,427 513,435 92,773,650
Receivable Turnover (TTM) 0.98 6.28 5.82
Inventory Turnover (TTM) -- 1.89 3.42
Asset Turnover (TTM) 0.00 0.32 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -52.94 6.37 10.65
Return on Assets - 5 Yr. Avg. -- 5.47 11.77
Return on Investment (TTM) -56.99 8.90 13.82
Return on Investment - 5 Yr. Avg. -- 6.78 15.32
Return on Equity (TTM) -67.22 10.04 15.24
Return on Equity - 5 Yr. Avg. -- 8.36 16.41
  1 Year 3 Year 5 Year
Sales % 37.59 -41.53 --
EPS (TTM) % -39.43 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Bellicum Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 13.25 9.34 99 99
13 Week -2.82 -7.55 89 95
26 Week -6.65 -13.75 88 97
52 Week -43.96 -52.50 44 70
YTD -16.52 -26.69 60 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 53.78%
# of Holders: 131
Total Shares Held: 24,744,759
3 Mo. Net Change: 657,289
# New Positions: 14
# Closed Positions: 16
# Increased Positions: 51
# Reduced Positions: 50
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.